Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis

被引:19
|
作者
D'hooghe, M. B. [1 ]
Haentjens, P. [2 ,3 ]
Nagels, G. [1 ,4 ]
Garmyn, M. [5 ]
De Keyser, J. [6 ,7 ]
机构
[1] Natl Ctr Multiple Sclerosis, B-1820 Melsbroek, Belgium
[2] Vrije Univ Brussel, Ctr Outcomes Res, Univ Ziekenhuis Brussel, Brussels, Belgium
[3] Vrije Univ Brussel, Expt Surg Lab, Univ Ziekenhuis Brussel, Brussels, Belgium
[4] Univ Mons, Serv Orthopedag Clin, Fac Psychol & Educ Sci, B-7000 Mons, Belgium
[5] Univ Ziekenhuizen, Dept Dermatol, Louvain, Belgium
[6] Vrije Univ Brussel, Dept Neurol UZ Brussel, Brussels, Belgium
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands
关键词
disability progression; epidemiology; multiple sclerosis; sun sensitivity; sunlight exposure; ULTRAVIOLET-RADIATION; STATUS SCALE; SKIN TYPE; VITAMIN-D; RISK; VALIDITY; POLYMORPHISMS; PREVALENCE; PHENOTYPE; MORTALITY;
D O I
10.1177/1352458511423778
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sunlight and vitamin D have been inversely associated with the risk of multiple sclerosis (MS). Objective: We investigated sunlight exposure and sun sensitivity in relation to disability progression in MS. Methods: We conducted a survey among persons with MS, registered by the Flemish MS society, Belgium, and stratified data according to relapsing-onset and progressive-onset MS. We used Kaplan-Meier survival and Cox proportional hazard regression analyses with time to Expanded Disability Status Scale (EDSS) 6 as outcome measure. Hazard ratios for the time from onset and from birth were calculated for the potentially predictive variables, adjusting for age at onset, gender and immunomodulatory treatment. Results: 704 (51.3%) of the 1372 respondents had reached EDSS 6. In relapsing-onset MS, respondents reporting equal or higher levels of sun exposure than persons of the same age in the last 10 years had a decreased risk of reaching EDSS 6. In progressive-onset MS, increased sun sensitivity was associated with an increased hazard of reaching EDSS 6. Conclusion: The association of higher sun exposure with a better outcome in relapsing-onset MS may be explained by either a protective effect or reverse causality. Mechanisms underlying sun sensitivity might influence progression in progressive-onset MS.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 50 条
  • [41] Evidence for a two-stage disability progression in multiple sclerosis
    Leray, Emmanuelle
    Yaouanq, Jacqueline
    Le Page, Emmanuelle
    Coustans, Marc
    Laplaud, David
    Oger, Joel
    Edan, Gilles
    BRAIN, 2010, 133 : 1900 - 1913
  • [42] Cortical lesion load associates with progression of disability in multiple sclerosis
    Calabrese, Massimiliano
    Poretto, Valentina
    Favaretto, Alice
    Alessio, Sara
    Bernardi, Valentina
    Romualdi, Chiara
    Rinaldi, Francesca
    Perini, Paola
    Gallo, Paolo
    BRAIN, 2012, 135 : 2952 - 2961
  • [43] Socioeconomic status and disability progression in multiple sclerosis A multinational study
    Harding, Katharine E.
    Wardle, Mark
    Carruthers, Robert
    Robertson, Neil
    Zhu, Feng
    Kingwell, Elaine
    Tremlett, Helen
    NEUROLOGY, 2019, 92 (13) : E1497 - E1506
  • [44] Disability progression in multiple sclerosis patients using early first-line treatments
    Lefort, Mathilde
    Vukusic, Sandra
    Casey, Romain
    Edan, Gilles
    Leray, Emmanuelle
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (09) : 2761 - 2771
  • [45] Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis
    Beretich, B. D.
    Beretich, T. M.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (08) : 891 - 898
  • [46] The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population
    Cierny, Daniel
    Lehotsky, Jan
    Kantorova, Ema
    Sivak, Stefan
    Javor, Juraj
    Kurta, Egon
    Dobrota, Dusan
    Michalik, Jozef
    NEUROLOGICAL RESEARCH, 2018, 40 (07) : 609 - 616
  • [47] Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis
    Sayonara Rangel Oliveira
    Tamires Flauzino
    Beatriz Sardinha Sabino
    Ana Paula Kallaur
    Daniela Frizon Alfieri
    Damacio Ramon Kaimen-Maciel
    Helena Kaminami Morimoto
    Elaine Regina Delicato de Almeida
    Marcell Alysson Batisti Lozovoy
    Edna Maria Vissoci Reiche
    Isaias Dichi
    Andréa Name Colado Simão
    Metabolic Brain Disease, 2018, 33 : 1393 - 1399
  • [48] Low testosterone is associated with disability in men with multiple sclerosis
    Bove, R.
    Musallam, A.
    Healy, B. C.
    Raghavan, K.
    Glanz, B. I.
    Bakshi, R.
    Weiner, H.
    De Jager, P. L.
    Miller, K. K.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1584 - 1592
  • [49] Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability
    Cerqueira Pinto, Simone Cotrim
    Ferreira Vasconcelos, Claudia Cristina
    Kallenbach Aurencao, Juliana Calvet
    Alvarenga, Marcos Papais
    das Gracas Gomes Camargo, Solange Maria
    Santos Thuler, Luiz Claudio
    Alvarenga, Regina Papais
    PEDIATRIC NEUROLOGY, 2019, 94 : 48 - 54
  • [50] Lipids in multiple sclerosis: adverse lipid profiles, disability and disease progression
    Tettey, Prudence
    van der Mei, Ingrid A. F.
    CLINICAL LIPIDOLOGY, 2014, 9 (05) : 473 - 475